Axonics Modulation Technologies

Yahoo Finance • last month

Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia

IRVINE, Calif., September 26, 2024--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics R20® rechargeable sacral n... Full story

Yahoo Finance • 9 months ago

Insider Sell: Chief Medical Officer Karen Noblett Sells 11,288 Shares of Axonics Inc (AXNX)

On January 31, 2024, Chief Medical Officer Karen Noblett executed a sale of 11,288 shares of Axonics Inc (NASDAQ:AXNX). The transaction was filed with the SEC and can be viewed through the SEC Filing. This sale is part of a series of insid... Full story

Yahoo Finance • 9 months ago

Boston Scientific Announces Results for Fourth Quarter and Full Year 2023

MARLBOROUGH, Mass., Jan. 31, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.725 billion during the fourth quarter of 2023, growing 14.9 percent on a reported basis, 14.5 percent on an operational1... Full story

Yahoo Finance • 12 months ago

Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities

IRVINE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- NeuroQure has embarked on a transformative journey aimed at revolutionizing the treatment landscape for Fragile X Syndrome and Autism Spectrum Disorder (ASD). With an unwavering commitmen... Full story

Yahoo Finance • last year

13 Stocks to Buy with Exponential Growth

In this article, we will take a look at the 13 stocks to buy with exponential growth. To see more such companies, go directly to 5 Stocks to Buy with Exponential Growth. Optimism was prevailing in the US stock market on October 11 as inve... Full story

Yahoo Finance • last year

10 Best Revenue Growth Stocks to Buy

In this piece, we will take a look at the ten best revenue growth stocks to buy. If you want to skip over the latest news for the stock market and want to jump ahead to the top five stocks in this list, then take a look at 5 Best Revenue G... Full story

Yahoo Finance • last year

Axonics to Report Second Quarter 2023 Financial Results on July 27

IRVINE, Calif., June 29, 2023--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, will report second... Full story

Yahoo Finance • last year

What Makes Axonics (AXNX) Unique?

Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. The fund was up 11.20% in the first quarter compared to the Russell 2000 Grow... Full story

Yahoo Finance • 2 years ago

Axonics to Participate in the SUFU 2023 Winter Meeting

IRVINE, Calif., March 07, 2023--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is participating a... Full story

Yahoo Finance • 2 years ago

Axonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue Guidance

4Q22 total company net revenue expected to be $85.6 to $86.0 million, an increase of 61% y/y Fiscal year 2022 total company net revenue expected to be in the range of $273.6 million, an increase of 52% y/y Fiscal year 2023 revenue guidan... Full story

Yahoo Finance • 2 years ago

Should You Invest in Axonics (AXNX)?

Chartwell Investment Partners, an affiliate of Carillon Tower Advisers, an investment management company, released its “Carillon Chartwell Small Cap Growth Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here... Full story

Yahoo Finance • 2 years ago

2 Fast-Growing Healthcare Stocks to Buy and Hold

Vir Biotechnology (NASDAQ: VIR) and Axonics (NASDAQ: AXNX) are two of the fastest-growing healthcare companies in terms of revenue. Vir raised $142.9 million when it went public with an initial public offering (IPO) in 2019, while Axonics... Full story

Yahoo Finance • 2 years ago

Axonics® to Participate in the Piper Sandler Healthcare Conference

IRVINE, Calif., November 18, 2022--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, will participat... Full story

Yahoo Finance • 2 years ago

Axonics® Announces Pricing of Public Offering of Common Stock

IRVINE, Calif., August 03, 2022--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) ("Axonics"), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today... Full story

Yahoo Finance • 3 years ago

Nyxoah Nominates Raymond Cohen and Virginia Kirby for Appointment to Its Board of Directors

Nyxoah Nominates Raymond Cohen and Virginia Kirby for Appointment to Its Board of Directors Mont-Saint-Guibert, Belgium – May 6, 2022, 7:00am CET / 1:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medi... Full story

Yahoo Finance • 3 years ago

Nyxoah nomme Raymond Cohen et Virginia Kirby pour la nomination à son Conseil d'Administration

Nyxoah nomme Raymond Cohen et Virginia Kirby pour la nomination à son Conseil d'Administration Mont-Saint-Guibert, Belgique – 6 mai 2022, 7h00 CET / 1h00 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société ») opè... Full story